These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38795958)
1. A Roadmap for Improving Medicare's Application of Coverage With Evidence Development. Lakdawalla D; Tunis S; Neumann P; Whicher D; Zeitler E; Liden B Value Health; 2024 Sep; 27(9):1191-1195. PubMed ID: 38795958 [TBL] [Abstract][Full Text] [Related]
2. Coverage with evidence development: where are we now? Zeitler EP; Gilstrap LG; Coylewright M; Slotwiner DJ; Colla CH; Al-Khatib SM Am J Manag Care; 2022 Aug; 28(8):382-389. PubMed ID: 35981123 [TBL] [Abstract][Full Text] [Related]
3. Medicare's coverage of colorectal cancer drugs: a case study in evidence development and policy. Carino T; Williams RD; Colbert AM; Bridger P Health Aff (Millwood); 2006; 25(5):1231-9. PubMed ID: 16966718 [TBL] [Abstract][Full Text] [Related]
4. Coverage options for promising technologies: Medicare's 'coverage with evidence development'. Tunis SR; Pearson SD Health Aff (Millwood); 2006; 25(5):1218-30. PubMed ID: 16966717 [TBL] [Abstract][Full Text] [Related]
5. CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY. Chambers JD; Chenoweth MD; Pyo J; Cangelosi MJ; Neumann PJ Int J Technol Assess Health Care; 2015 Jan; 31(5):347-54. PubMed ID: 26750558 [TBL] [Abstract][Full Text] [Related]
6. Value-based interventional pain management: a review of medicare national and local coverage determination policies. Manchikanti L; Falco FJ; Benyamin RM; Helm S; Singh V; Hirsch JA Pain Physician; 2013; 16(3):E145-80. PubMed ID: 23703416 [TBL] [Abstract][Full Text] [Related]
7. Forcing isolation: Medicare's "in the home" coverage standard for wheelchairs. Medicare Rights Center Care Manag J; 2005; 6(1):29-37. PubMed ID: 16447855 [TBL] [Abstract][Full Text] [Related]
8. Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval. Neumann PJ; Crummer E; Chambers JD; Tunis SR Milbank Q; 2023 Dec; 101(4):1047-1075. PubMed ID: 37644739 [TBL] [Abstract][Full Text] [Related]
9. The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development. Lindsay MJ; Siegel BA; Tunis SR; Hillner BE; Shields AF; Carey BP; Coleman RE AJR Am J Roentgenol; 2007 Apr; 188(4):1109-13. PubMed ID: 17377055 [TBL] [Abstract][Full Text] [Related]
11. Authority of Medicare to Limit Coverage of FDA-Approved Products: Legal and Policy Considerations. Daval CJR; Kesselheim AS JAMA Intern Med; 2023 Sep; 183(9):999-1004. PubMed ID: 37505487 [TBL] [Abstract][Full Text] [Related]
12. How changes in the Medicare coverage process have facilitated the spread of new technologies. Straube BM Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-314-W5-316. PubMed ID: 15975989 [TBL] [Abstract][Full Text] [Related]
13. Medicare's national coverage decisions for technologies, 1999-2007. Neumann PJ; Kamae MS; Palmer JA Health Aff (Millwood); 2008; 27(6):1620-31. PubMed ID: 18997221 [TBL] [Abstract][Full Text] [Related]
14. Recent proposals to limit Medigap coverage and modify Medicare cost sharing. Linehan K Issue Brief George Wash Univ Natl Health Policy Forum; 2012 Feb; (845):1-19. PubMed ID: 22420066 [TBL] [Abstract][Full Text] [Related]
15. Focus on locus: evolution of Medicare's local coverage policy. Foote SB Health Aff (Millwood); 2003; 22(4):137-46. PubMed ID: 12889761 [TBL] [Abstract][Full Text] [Related]
16. Looking at CER from Medicare's perspective. Mohr P J Manag Care Pharm; 2012 May; 18(4 Suppl A):S5-8. PubMed ID: 22578211 [TBL] [Abstract][Full Text] [Related]